Elevage Medical Technologies

Nuclera specializes in accelerating drug discovery by providing a protein prototyping system. Its eProtein Discovery™ platform enables scientists to rapidly produce and test proteins for research purposes.

Moximed develops and provides the Atlas System, an implantable joint unloader designed to alleviate pain and preserve mobility in patients with medial compartment knee osteoarthritis. Its outpatient treatment option aims to improve quality of life for those not responsive to other therapies or candidates for knee replacement.

4basebio AG is a biotechnology company based in Heidelberg, Germany, specializing in the manufacturing of DNA products for therapeutic applications and research. The company provides a range of research and diagnostic tools, utilizing its proprietary enzymes, including RNA reverse transcriptase, DNA polymerase, and DNA primase. 4basebio serves the fast-growing gene therapy market and aims to enable advancements in medical science and patient care. Formerly known as Expedeon AG, the company rebranded to 4basebio AG in January 2020, reflecting its focus on life science technology and DNA manufacturing. Its products cater to both European and international markets, addressing the needs of researchers and healthcare professionals.

Based in Boston's biotech hub, Elucid improves cardiovascular diagnostic imaging via machine learning. Its flagship product, ElucidVivo, is the first FDA-cleared software for evaluating plaque vulnerability from a single CT scan to inform risk assessment and treatment selection.